Annual CAPEX
$1.22 M
+$14.00 K+1.16%
31 December 2023
Summary:
Foghorn Therapeutics annual capital expenditures is currently $1.22 million, with the most recent change of +$14.00 thousand (+1.16%) on 31 December 2023. During the last 3 years, it has fallen by -$14.96 million (-92.44%). FHTX annual CAPEX is now -92.44% below its all-time high of $16.18 million, reached on 31 December 2020.FHTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$309.00 K
+$292.00 K+1717.65%
30 September 2024
Summary:
Foghorn Therapeutics quarterly capital expenditures is currently $309.00 thousand, with the most recent change of +$292.00 thousand (+1717.65%) on 30 September 2024. Over the past year, it has increased by +$227.00 thousand (+276.83%). FHTX quarterly CAPEX is now -95.87% below its all-time high of $7.49 million, reached on 31 December 2020.FHTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$464.00 K
+$227.00 K+95.78%
30 September 2024
Summary:
Foghorn Therapeutics TTM capital expenditures is currently $464.00 thousand, with the most recent change of +$227.00 thousand (+95.78%) on 30 September 2024. Over the past year, it has dropped by -$992.00 thousand (-68.13%). FHTX TTM CAPEX is now -97.08% below its all-time high of $15.92 million, reached on 30 June 2021.FHTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | +276.8% | -68.1% |
| 3 y3 years | -92.4% | +34.4% | -95.7% |
| 5 y5 years | - | - | - |
FHTX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.4% | +1.2% | -51.4% | +1717.7% | -95.7% | +95.8% |
| 5 y | 5 years | -92.4% | +1.2% | -95.9% | +1717.7% | -97.1% | +95.8% |
| alltime | all time | -92.4% | +1.2% | -95.9% | +1717.7% | -97.1% | +95.8% |
Foghorn Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $309.00 K(+1717.6%) | $464.00 K(+95.8%) |
| June 2024 | - | $17.00 K(-83.2%) | $237.00 K(-65.6%) |
| Mar 2024 | - | $101.00 K(+173.0%) | $689.00 K(-43.7%) |
| Dec 2023 | $1.22 M(+1.2%) | $37.00 K(-54.9%) | $1.22 M(-15.9%) |
| Sept 2023 | - | $82.00 K(-82.5%) | $1.46 M(-14.6%) |
| June 2023 | - | $469.00 K(-26.3%) | $1.70 M(+6.6%) |
| Mar 2023 | - | $636.00 K(+136.4%) | $1.60 M(+32.1%) |
| Dec 2022 | $1.21 M | $269.00 K(-18.5%) | $1.21 M(+18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $330.00 K(-9.3%) | $1.02 M(+10.9%) |
| June 2022 | - | $364.00 K(+47.4%) | $921.00 K(-47.8%) |
| Mar 2022 | - | $247.00 K(+208.8%) | $1.77 M(-46.7%) |
| Dec 2021 | $3.31 M(-79.5%) | $80.00 K(-65.2%) | $3.31 M(-69.1%) |
| Sept 2021 | - | $230.00 K(-81.0%) | $10.72 M(-32.6%) |
| June 2021 | - | $1.21 M(-32.6%) | $15.92 M(+8.2%) |
| Mar 2021 | - | $1.79 M(-76.0%) | $14.71 M(+13.9%) |
| Dec 2020 | $16.18 M | $7.49 M(+38.0%) | $12.91 M(+138.0%) |
| Sept 2020 | - | $5.42 M | $5.42 M |
FAQ
- What is Foghorn Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual CAPEX year-on-year change?
- What is Foghorn Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly CAPEX year-on-year change?
- What is Foghorn Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM CAPEX year-on-year change?
What is Foghorn Therapeutics annual capital expenditures?
The current annual CAPEX of FHTX is $1.22 M
What is the all time high annual CAPEX for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual capital expenditures is $16.18 M
What is Foghorn Therapeutics annual CAPEX year-on-year change?
Over the past year, FHTX annual capital expenditures has changed by +$14.00 K (+1.16%)
What is Foghorn Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of FHTX is $309.00 K
What is the all time high quarterly CAPEX for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly capital expenditures is $7.49 M
What is Foghorn Therapeutics quarterly CAPEX year-on-year change?
Over the past year, FHTX quarterly capital expenditures has changed by +$227.00 K (+276.83%)
What is Foghorn Therapeutics TTM capital expenditures?
The current TTM CAPEX of FHTX is $464.00 K
What is the all time high TTM CAPEX for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM capital expenditures is $15.92 M
What is Foghorn Therapeutics TTM CAPEX year-on-year change?
Over the past year, FHTX TTM capital expenditures has changed by -$992.00 K (-68.13%)